Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Open House Drug Rebate Agreements Sarilumab, Atc L04ac14 2026-09-05
Germany Open House Drug Discount Agreements Piribedil, Atc N04bc08 2026-09-05
Germany Open House Drug Rebate Agreements Sorafenib, Atc L01ex02 2026-09-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For The Active Allergen Extract Of Various Origins (subcutaneous Injections; V01aa02, V01aa03, V01aa05), For The Period 01.11.2024 31.10.2026 2026-09-05
Germany Open Framework Agreement On Drug Discounts Pursuant To Section 130a Para. 8 Sgb V With The Possibility Of Joining At Any Time, So-called Approval Model 202409 2026-09-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For Medicinal Products Containing The Active Ingredient Estriol (atc Code 2026-09-27
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For Medicinal Products Containing The Active Ingredient Vildagliptin (atc Code 2026-09-27
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For Medicinal Products Containing The Active Ingredient Omalizumab (atc Code 2026-09-27
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For Medicinal Products Containing The Active Ingredient Testosterone (atc 2026-09-27
Bulgaria Dynamic System For Purchases Of Medicinal Products For The Needs Of "mbalsvoge" Llc For A Period Of 2 Years 2026-09-28
Whats app